Speaker illustration

Professor Eva Lonn

Population Health Research Institute, Hamilton (Canada)

Member of:

European Society of Cardiology

Blood Pressure Levels for Initiation of Antihypertensive Drug Therapy and Targets of Blood Pressure Lowering in Intermediate Risk People without Cardiovascular Disease: Insights from the HOPE-3 Trial

Event: ESC CONGRESS 2017

Topic: Treatment of hypertension

Session: Clinical Trial Update 2


This platform is supported by

logo Novo Nordisk